A federal probe is underway into the World Professional Association for Transgender Health (WPATH), the leading authority on transgender medical treatment, over allegations that its guidelines for pediatric gender treatments are based on limited evidence. The Federal Trade Commission (FTC) and attorneys general of Alaska, Iowa, Nebraska, and Texas filed a complaint in a Texas federal court, accusing WPATH of developing and promoting guidance that healthcare providers relied upon when recommending puberty blockers, cross-sex hormones, and sex-change procedures for minors.
Allegations of Deceptive Practices
The complaint alleges that WPATH publicly described its Standards of Care as evidence-based and rooted in expert consensus, while some of the organization’s own leaders privately acknowledged limitations in the available evidence. The FTC claims that WPATH removed age minimums from its 2022 Standards of Care for procedures, including breast removal surgeries, without scientific justification.
According to the complaint, internal discussions revealed that some WPATH leaders struggled to identify evidence-based reasons supporting the change. The FTC also alleges that many of the clinicians and surgeons who helped draft WPATH’s guidelines had financial and professional interests tied to the treatments being recommended.
Implications for Pediatric Gender Treatments
The lawsuit could determine whether the medical guidance that shaped transgender treatment for thousands of children was built on solid evidence or agenda-driven speculation. The case has sparked concerns about the potential harm caused by these treatments, with some minors experiencing lasting complications, including chronic pain, sexual dysfunction, and fertility concerns.
Kurt Miceli, chief medical officer for Do No Harm, a medical ethics advocacy organization, said the allegations raise serious questions about how WPATH’s guidelines were developed. ‘The conflicts of interest that are within the standards of care are significant, and again, not brought to light, and this is part of that deception, and the concern that WPATH has sort of stated that the science is there behind pediatric medical transition when it is not,’ Miceli said.
Original reporting: Fox News (HLL/CB) — read the source article.
